GLOBAL FOREX NEWS

View all

Aug28

Mixed Results for U.S. Durable Goods Orders Pressure the Greenback

Mixed Results for U.S. Durable Goods Orders Pressure the Greenback July’s U.S. Core Durable Goods Orders declined by -0.8 percent, notably lower than the increase of +0.5 percent market analysts expected. Read more
Aug27

Signal Trading of the Day at Fxwire.com

Signal Trading of the Day at Fxwire.com Risk sentiment boosting EM currencies; time for carry trades The dollar was higher this morning against most of its G10 counterparts Read more
Aug26

The Professionalism of EXNESS’ Support Team

The Professionalism of EXNESS’ Support Team EXNESS’ customer support team is highly professional & responsive. Available in 13 languages, you will be able to deal with any forex trading problems easily. Read more
Aug25

Free Tips for Successful Forex Trading

Free Tips for Successful Forex Trading Do you want to make huge profits from forex trading? Read these free tips to enhance your chances of becoming a successful forex trader. Read more
Aug22

Critical Forex Trading Mistakes to Avoid

Critical Forex Trading Mistakes to Avoid All online traders are prone to making occasional forex trading mistakes. Read these critical forex trading mistakes and avoid them at your peril! Read more
Aug21

Are EXNESS Tight Spreads Really so Important?

Are EXNESS Tight Spreads Really so Important? EXNESS offers some of the tightest and most competitive spreads in the industry. Find out more about the many benefits of tight spreads! Read more

TOP REUTERS NEWS

View all

by Reuters Business News / 05.26.2014
LONDON/NEW YORK (Reuters) - Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the... Read more
by Reuters Business News / 05.21.2014
LONDON (Reuters) - Pfizer's chances of striking a deal to buy AstraZeneca in the coming days look vanishingly small, but the notion it could return later this year is propping up the British... Read more
by Reuters Business News / 05.20.2014
LONDON (Reuters) - Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer, puncturing the U.S. drugmaker's plan for a merger to create the world's biggest pharmaceuticals... Read more
by Reuters Business News / 05.19.2014
LONDON (Reuters) - U.S. drugmaker Pfizer said on Sunday it had raised its offer for British rival AstraZeneca to 69.3 billion pounds ($116.6 billion), or 55 pounds a share, and would walk away if... Read more
by Reuters Business News / 05.14.2014
LONDON (Reuters) - Pfizer said it would ringfence the development of important drugs if it acquired AstraZeneca , rejecting a charge from the British company that a takeover would disrupt important... Read more
by Reuters Business News / 05.13.2014
LONDON (Reuters) - U.S. drugmaker Pfizer hinted it could raise its proposed $106 billion offer if AstraZeneca would only engage in talks, as its boss was grilled by UK lawmakers on his commitment to... Read more
by Reuters Business News / 05.12.2014
LONDON (Reuters) - Pfizer defended the business case behind its plan to acquire AstraZeneca on Monday and questioned the UK drugmaker's ability to stand alone for much longer as the New York-based... Read more
by Reuters Business News / 05.08.2014
(Reuters) - Wellcome Trust, Britain's biggest medical research foundation said it had "major concerns" about U.S. drug major Pfizer's 63 billion pound offer for AstraZeneca , the Financial Times... Read more
by Reuters Business News / 05.08.2014
(Reuters) - Molycorp Inc shares slumped 17 percent on Thursday in the wake of the U.S.-based rare earths producer's results a day earlier which showed a bigger first-quarter loss and production... Read more
by Reuters Business News / 05.08.2014
(Reuters) - Cable TV broadcaster AMC Networks Inc said it expects slower advertising growth this quarter as its latest series, "Turn", draws fewer viewers than its older hits, sending its shares down... Read more

Warning: Trading forex and CFDs on margin can result in the loss of your entire invested capital. Forex, CFDs and other instruments are not suitable for every person. You should only speculate with money you can afford to lose. Before trading you should fully understand the risks involved and take into consideration your level of experience.